Evidence map›Paper›PMID 28917036›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2018

Selenocysteine tRNA

Bradley A Carlson, Byeong Jae Lee, Petra A Tsuji, Paul R Copeland, Ulrich Schweizer, Vadim N Gladyshev, Dolph L Hatfield

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. tRNA Function and Dysregulation in Cancer.Frontiers in cell and developmental biology · 2022
    Review
  7. Review
  8. Article
  9. The Effect of tRNAInternational journal of molecular sciences · 2021
    Article
  10. Review
  11. Article
  12. Effects of selenium supplementation on diet-induced obesity in mice with a disruption of the selenocysteine lyase gene.Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) · 2020
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 3 countries.

Bradley A CarlsonMolecular Biology of Selenium Section, Mouse Cancer Genetics Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20814, USA. carlsonb@mail.nih.gov.
Byeong Jae LeeSchool of Biological Sciences, Seoul National University, Seoul, South Korea.
Petra A TsujiDepartment of Biological Sciences, Towson University, Towson, MD, USA.
Paul R CopelandDepartment of Biochemistry and Molecular Biology, Rutgers-Robert Wood Johnson Medical School, Piscataway, NJ, USA.
Ulrich SchweizerInstitut für Biochemie und Molekularbiologie, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.
Vadim N GladyshevDivision of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Dolph L HatfieldMolecular Biology of Selenium Section, Mouse Cancer Genetics Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20814, USA.
National Cancer Institute · USHarvard University · USJohnson University · USSeoul National University · KRTowson University · USUniversity of Bonn · DE

Funding

Functional Analysis of SBP2 and Selenocysteine IncorporationR01GM077073 · NIGMS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI COPELAND, PAUL R · 2006 to 2022
$5.5M
Selenoproteins as Targets for Cancer PreventionR01CA080946 · NCI · UNIVERSITY OF NEBRASKA LINCOLN · PI GLADYSHEV, VADIM N. · 2001 to 2018
$4.5M
Mechanisms of lifespan controlDP1AG047745 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI GLADYSHEV, VADIM N. · 2013 to 2018
$4.4M
IDENTITY OF TERMINATOR AND SELENOCYSTEINE UGA CODONSR01GM061603 · NIGMS · UNIVERSITY OF NEBRASKA LINCOLN · PI GLADYSHEV, VADIM N. · 2000 to 2016
$4.0M
Functions of thioredoxin reductases and their targetsR37GM065204 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI GLADYSHEV, VADIM N. · 2011 to 2020
$4.0M
Functions of Mammalian Thioredoxin ReductasesR01GM065204 · NIGMS · UNIVERSITY OF NEBRASKA LINCOLN · PI GLADYSHEV, VADIM N. · 2002 to 2009
$2.2M
Development of a zebrafish model for selenoprotein synthesis and functionR21HD083616 · NICHD · RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL · PI COPELAND, PAUL R · 2016 to 2017
$428k
NCI NIH HHS R01 CA080946NIA NIH HHS DP1 AG047745NICHD NIH HHS R21 HD083616NIGMS NIH HHS R01 GM061603NIGMS NIH HHS R01 GM065204NIGMS NIH HHS R01 GM077073NIGMS NIH HHS R37 GM065204
6 · The paper itself

Abstract

The selenocysteine (Sec) tRNA

Indexed as

AnimalsBlotting, NorthernChromatography, AffinityChromatography, Reverse-PhaseHumansIsotope LabelingNucleic Acid ConformationProtein BiosynthesisRNA, Transfer, Amino Acid-SpecificSelenium RadioisotopesSelenoproteinsSequence Analysis, RNARNA, Transfer, Amino Acid-SpecificSelenium RadioisotopesSelenoproteinstRNA, selenocysteine-ChromatographyGel electrophoresisSeleniumSelenocysteine tRNASelenocysteine tRNA detectionSelenocysteine tRNA gene modification

Identifiers

PMID28917036
PMCPMC5836751
OpenAlexW2754314659

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.